Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NARATRIPTAN vs NATALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NARATRIPTAN vs NATALIZUMAB: Safety Overview

Metric NARATRIPTAN NATALIZUMAB
Total FAERS Reports 526 64,315
Deaths Reported 9 3,140
Death Rate 1.7% 4.9%
Hospitalizations 102 17,879
Average Patient Age 49.2 yrs 45.6 yrs
% Female Patients 90.0% 78.5%
FDA Approval Date Apr 22, 2011 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Sandoz Inc
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription